Diabetes is associated with an excess release of neutrophil extracellular traps (NETs) and an enhanced NETosis, a neutrophil cell death programme instrumental to anti-microbial defences, but also involved in tissue damage. We herein investigated whether the antidiabetic drug metformin protects against NETosis.

The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo

Menegazzo, Lisa;Scattolini, Valentina;Cappellari, Roberta;Bonora, Benedetta Maria;Albiero, Mattia;Bortolozzi, Mario;Romanato, Filippo;Ceolotto, Giulio;Avogaro, Angelo;Fadini, Gian Paolo
2018

Abstract

Diabetes is associated with an excess release of neutrophil extracellular traps (NETs) and an enhanced NETosis, a neutrophil cell death programme instrumental to anti-microbial defences, but also involved in tissue damage. We herein investigated whether the antidiabetic drug metformin protects against NETosis.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3286029
Citazioni
  • ???jsp.display-item.citation.pmc??? 36
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 58
social impact